Login / Register
  • Home
    • Home
    • Data/Tissue Request
    • People
    • Administrator
      • Current Users
      • Study Download
  • Resource Descriptions
    • CHARTER Research Study
    • Experimental Studies
  • Data Query Tools
    • CHARTER Research Study
    • Experimental Studies
    • NNTC Clinical Data

Query Tool

  • Demographics
  • Study Characteristics
  • Comorbidities
  • CNS Diagnoses
  • ARV Exposure
  • Psychiatric Profile
  • Specimen Inventory
  • Laboratory Data
  • Neuropsych Profile
  • Soluble biomarker data
  • Peripheral neuropathy

                                                                      

Demographics

Age Range:   

Gender:   

Race/Ethnicity:   

Education:   

Time since diagnosis with HIV:   

Study Characteristics

Study/Substudy cohorts of interest:   

Year of enrollment into cross-sectional cohort:   

Number of visits in CHARTER study:   

Number of years enrolled in longtitutional CHARTER substudy:   

Comorbidities

Evidence for hypertension :   

Evidence for diabetes :   

Evidence for hyperlipidemia :   

Evidence for viral hepatitis :   

Evidence for liver disease:   

Evidence for renal disease:   

Evidence for COPD:   

Evidence for cerebrovascular disease:   

Evidence for non-AIDS defining cancer:   

Evidence for lipodystrophy:   

Evidence for tobacco use:   

CNS Diagnoses

Diagnosis of CNS Lymphoma:   

Diagnosis of Toxoplasmosis of Brain:   

Diagnosis of Progressive Multifocal Leukoencephalopathy (PML):   

Diagnosis of Extrapulmonary Cryptococcosis:   

Diagnosis of Disseminated or Extrapulmonary Histoplasmosis:   

Diagnosis of Disseminated or Extrapulmonary Coccidiodomyccosis:   

ARV Exposure

Current ARV regimen classification:     

Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Current Exposure Ever Used
3TC – Lamivudine (Epivir)
ABC – Abacavir sulfate (Ziagen)
D4T – Stavudine (Zerit)
DDC – Zalcitabine/dideoxycytidine (Hivid)
DDI – Didanosine (Videx)
FTC – Emtricitabine (Emtriva)
TDF – Tenofovir disoproxil fumarate (Viread)
ZDV – Zidovudine (Retrovir)

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Current Exposure Ever Used
DLV – Delavirdine mesylate (Rescriptor)
EFV - Efavirenz (Sustiva)
ETR – Etravirine (Intelence)
NVP – Nevirapine (Viramune/Viramune extended release)
RPV – Rilpivirine hydrochloride (Edurant)

Protease Inhibitors (PIs) Current Exposure Ever Used
ATV – Atazanavir sulfate (Reyataz)
APV – Amprenavir (Agenerase)
DRV – Darunavir ethanolate (Prezista)
FPV – Fosamprenavir calcium (Lexiva)
IDV – Indinavir sulfate (Crixivan)
LPV – Lopinavir (ABT-378 – prescribed with RTV in combination ARV Kaletra)
NFV – Nelfinavir mesylate (Viracept)
RTV – Ritonavir (Norvir)
SQV – Saquinavir mesylate (Invirase)
SQV2 – Saquinavir sgc (Fortovase)
TPV – Tipranavir (Aptivus)

Fusion Inhibitors Current Exposure Ever Used
T-20 – Enfuviritide/Pentafuside (Fuzeon)

Entry Inhibitors Current Exposure Ever Used
MVC – Maraviroc (Selzentry)

Integrase Inhibitors Current Exposure Ever Used
DTG – Dolutegravir (Tivicay)
EVG – Elvitegravir (Vitekta)
RAL – Raltegravir potassium (Isentress)

Pharmacokinetic Enhancers Current Exposure Ever Used
COBI - Cobicistat (Tybost)

Other/Experimental anti-HIV medications Current Exposure Ever Used
BDT - Unknown blinded study ARV - Two
BSD - Unknown blinded study ARV
Psychiatric Profile

Beck Depression Inventory Administration:   

CIDI Diagnosis:   

Current diagnosis of major depressive disorder:   

Lifetime diagnosis of major depressive disorder:   

Current diagnosis of persistent depressive disorder:   

Lifetime diagnosis of persistent depressive disorder:   

Current alcohol abuse/dependence:   

Lifetime alcohol abuse/dependence:   

Current cannabis abuse/dependence:   

Lifetime cannabis abuse/dependence:   

Current cocaine abuse/dependence:   

Lifetime cocaine abuse/dependence:   

Current hallucinogen abuse/dependence:   

Lifetime hallucinogen abuse/dependence:   

Current opiate abuse/dependence:   

Lifetime opiate abuse/dependence:   

Current sedative abuse/dependence:   

Lifetime sedative abuse/dependence:   

Current amphetamine abuse/dependence:   

Lifetime amphetamine abuse/dependence:   

Current other drug abuse/dependence:   

Lifetime other drug abuse/dependence:   

Specimen Inventory

Availability of cerebrospinal fluid:   

Availability of CSF pellets:   

Availability of DNA:   

Availablility of PAXgene blood DNA tubes:   

Availability of PAXgene blood RNA tubes:   

Availability of peripheral blood mononuclear cells:   

Availability of blood plasma:   

Availablility of blood serum:   

Availability of whole blood:   

Laboratory

Log(base 10) Plasma Viral Load Range (IU/mL) Range:   

Absolute CD4 Concentration (cells/uL) Range:   

Nadir CD4 value:   

Vital Signs Data Available:   

Urine Toxicology Screening Results From Day of Testing:   

SNP Data Availability Flag:   

Neuropsych Profile: Impairment is defined as a domain T-score <40. Average Global impairment refers to average domain T-score <40.

Current Abstract and Executive Functioning domain impairment:   

Current Speed of Information Processing domain impairment:   

Current Attention and Working Memory domain impairment:   

Current Learning domain impairment:   

Current Memory domain impairment:   

Current Verbal Fluency domain impairment:   

Current Motor domain impairment:   

Current Average Global impairment:   

Fluid assayed:   

Biomarker gene name of interest:   

The biomarker data tool uses the HUGO Gene names to identify biomarkers of interest. For more information on the index or to identify the gene symbol relevant to your soluble biomarker of interest, please visit the HUGO Gene Index

Severity of distal sensory polyneuropathy symptoms (independent of DSPN diagnosis)   

Diagnosis of distal sensory polyneuropathy   

Etiology of distal sensory polyneuropathy   

Intraepidermal nerve fiber density data availability   
Results:

For support and general inquires please contact:

  • Address:National NeuroAIDS Tissue Consortium
    S 42nd St & Emile St. Omaha, NE 68198
  • Phone:(402) 559-7174
  • Email:nntc-dcc@unmc.edu

Sponsored by a U24 grant mechanism from the NIMH/NIH U24MH100925